TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP2007	Iron metabolism in placenta	0.00223324587057408	-6.10429920444971	12	2	0.0625	32	5314	2495,30061	FTH1,SLC40A1
WP3527	Preimplantation Embryo	0.00537875774520859	-5.22529783384809	60	3	0.09375	32	5314	79923,2354,6597	NANOG,FOSB,SMARCA4
WP2884	NRF2 pathway	0.010068478038909	-4.59834572181629	143	4	0.125	32	5314	23764,2495,54578,2512	MAFF,FTH1,UGT1A6,FTL
WP2112	IL17 signaling pathway	0.0146527533944539	-4.2231270161646	31	2	0.0625	32	5314	6885,3717	MAP3K7,JAK2
WP231	TNF alpha Signaling Pathway	0.0183516711231679	-3.99803463924568	94	3	0.09375	32	5314	6885,10010,56957	MAP3K7,TANK,OTUD7B
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.0238772941466312	-3.73482730732043	4	1	0.03125	32	5314	3717	JAK2
WP364	IL-6 signaling pathway	0.0272099520759575	-3.60417248745433	43	2	0.0625	32	5314	3717,6885	JAK2,MAP3K7
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.0283998528140278	-3.56137131643306	44	2	0.0625	32	5314	839,6885	CASP6,MAP3K7
WP2637	Structural Pathway of Interleukin 1 (IL-1)	0.0359652392594264	-3.325202383122	50	2	0.0625	32	5314	6885,10010	MAP3K7,TANK
WP3865	RIG-I-like Receptor Signaling	0.0515834493373232	-2.96455440722235	61	2	0.0625	32	5314	10010,6885	TANK,MAP3K7
WP561	Heme Biosynthesis	0.0529481045871122	-2.93844300385281	9	1	0.03125	32	5314	212	ALAS2
WP288	NLR Proteins	0.0529481045871122	-2.93844300385281	9	1	0.03125	32	5314	6885	MAP3K7
WP2513	Nanoparticle triggered regulated necrosis	0.0643400358717337	-2.74357319963747	11	1	0.03125	32	5314	2512	FTL
WP437	EGF/EGFR Signaling Pathway	0.0724148534536988	-2.62534384243227	162	3	0.09375	32	5314	9101,3717,2354	USP8,JAK2,FOSB
WP382	MAPK Signaling Pathway	0.0811189426282888	-2.51183877388535	170	3	0.09375	32	5314	839,3164,6885	CASP6,NR4A1,MAP3K7
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	0.0977250119052536	-2.32559774547909	17	1	0.03125	32	5314	2034	EPAS1
WP2355	Corticotropin-releasing hormone signaling pathway	0.107217547708207	-2.23289535243349	93	2	0.0625	32	5314	2354,3164	FOSB,NR4A1
WP384	Apoptosis Modulation by HSP70	0.108594672666631	-2.22013292732059	19	1	0.03125	32	5314	839	CASP6
WP697	Estrogen metabolism	0.108594672666631	-2.22013292732059	19	1	0.03125	32	5314	54578	UGT1A6
WP2377	Integrated Pancreatic Cancer Pathway	0.113638777914316	-2.17473047606386	197	3	0.09375	32	5314	5273,7159,2512	SERPINB10,TP53BP2,FTL
WP2507	Nanomaterial induced apoptosis	0.119337431436571	-2.12580024019196	21	1	0.03125	32	5314	839	CASP6
WP272	Blood Clotting Cascade	0.124661671412969	-2.08215183991842	22	1	0.03125	32	5314	2159	F10
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	0.124661671412969	-2.08215183991842	22	1	0.03125	32	5314	6597	SMARCA4
WP399	Wnt Signaling Pathway and Pluripotency	0.133027670403683	-2.0171981242514	106	2	0.0625	32	5314	79923,6885	NANOG,MAP3K7
WP262	EBV LMP1 signaling	0.13521676162953	-2.00087614650795	24	1	0.03125	32	5314	6885	MAP3K7
WP581	EPO Receptor Signaling	0.145648506300536	-1.9265590510324	26	1	0.03125	32	5314	3717	JAK2
WP698	Glucuronidation	0.145648506300536	-1.9265590510324	26	1	0.03125	32	5314	54578	UGT1A6
WP241	One Carbon Metabolism	0.166147525454263	-1.79487917773654	30	1	0.03125	32	5314	2618	GART
WP3851	TLR4 Signaling and Tolerance	0.166147525454263	-1.79487917773654	30	1	0.03125	32	5314	6885	MAP3K7
WP408	Oxidative Stress	0.171197351188347	-1.76493828742487	31	1	0.03125	32	5314	54578	UGT1A6
WP2875	Constitutive Androstane Receptor Pathway	0.176217545160917	-1.73603599517675	32	1	0.03125	32	5314	54578	UGT1A6
WP400	p38 MAPK Signaling Pathway	0.186169710094435	-1.68109660140836	34	1	0.03125	32	5314	6885	MAP3K7
WP366	TGF-beta Signaling Pathway	0.190348144502006	-1.65890054402354	133	2	0.0625	32	5314	6885,2354	MAP3K7,FOSB
WP619	Type II interferon signaling (IFNG)	0.200879896807285	-1.60504807783622	37	1	0.03125	32	5314	3717	JAK2
WP383	Striated Muscle Contraction	0.20572580230218	-1.58121105362104	38	1	0.03125	32	5314	7171	TPM4
WP170	Nuclear Receptors	0.210543234890833	-1.55806425554425	39	1	0.03125	32	5314	3164	NR4A1
WP127	IL-5 Signaling Pathway	0.215332356496369	-1.5355726002725	40	1	0.03125	32	5314	3717	JAK2
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	0.224826310056244	-1.49242713019422	42	1	0.03125	32	5314	6885	MAP3K7
WP2332	Interleukin-11 Signaling Pathway	0.23420894070869	-1.45154165301905	44	1	0.03125	32	5314	3717	JAK2
WP2857	Mesodermal Commitment Pathway	0.241498309405753	-1.42089280630427	156	2	0.0625	32	5314	3717,79923	JAK2,NANOG
WP465	Tryptophan metabolism	0.243481512155249	-1.41271426478243	46	1	0.03125	32	5314	7337	UBE3A
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.248076916790252	-1.39401643255542	47	1	0.03125	32	5314	3717	JAK2
WP2873	Aryl Hydrocarbon Receptor Pathway	0.252645274233278	-1.37576885221521	48	1	0.03125	32	5314	54578	UGT1A6
WP286	IL-3 Signaling Pathway	0.257186738576844	-1.35795284869119	49	1	0.03125	32	5314	3717	JAK2
WP363	Wnt Signaling Pathway Netpath	0.27508671702121	-1.2906688964005	53	1	0.03125	32	5314	6885	MAP3K7
WP2406	Cardiac Progenitor Differentiation	0.27508671702121	-1.2906688964005	53	1	0.03125	32	5314	79923	NANOG
WP107	Translation Factors	0.27508671702121	-1.2906688964005	53	1	0.03125	32	5314	1915	EEF1A1
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.283879291896416	-1.25920615970491	55	1	0.03125	32	5314	6885	MAP3K7
WP395	IL-4 Signaling Pathway	0.283879291896416	-1.25920615970491	55	1	0.03125	32	5314	3717	JAK2
WP2272	Pathogenic Escherichia coli infection	0.283879291896416	-1.25920615970491	55	1	0.03125	32	5314	10095	ARPC1B
WP2795	Cardiac Hypertrophic Response	0.292568513890932	-1.22905640421453	57	1	0.03125	32	5314	6885	MAP3K7
WP195	IL-1 signaling pathway	0.292568513890932	-1.22905640421453	57	1	0.03125	32	5314	6885	MAP3K7
WP558	Complement and Coagulation Cascades	0.305411129466991	-1.18609644459903	60	1	0.03125	32	5314	2159	F10
WP304	Kit receptor signaling pathway	0.305411129466991	-1.18609644459903	60	1	0.03125	32	5314	3717	JAK2
WP61	Notch Signaling Pathway	0.313847086539321	-1.15884939723342	62	1	0.03125	32	5314	3717	JAK2
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.313847086539321	-1.15884939723342	62	1	0.03125	32	5314	6885	MAP3K7
WP3584	MECP2 and Associated Rett Syndrome	0.313847086539321	-1.15884939723342	62	1	0.03125	32	5314	7337	UBE3A
WP2324	AGE/RAGE pathway	0.330422253807162	-1.1073838854656	66	1	0.03125	32	5314	3717	JAK2
WP2374	Oncostatin M Signaling Pathway	0.330422253807162	-1.1073838854656	66	1	0.03125	32	5314	3717	JAK2
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.338563714384804	-1.0830429786853	68	1	0.03125	32	5314	3717	JAK2
WP2369	Histone Modifications	0.342598400076583	-1.07119636304878	69	1	0.03125	32	5314	79813	EHMT1
WP176	Folate Metabolism	0.342598400076583	-1.07119636304878	69	1	0.03125	32	5314	2618	GART
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.362416847138421	-1.01496021820503	74	1	0.03125	32	5314	950	SCARB2
WP2037	Prolactin Signaling Pathway	0.37018108301098	-0.993762979524424	76	1	0.03125	32	5314	3717	JAK2
WP2034	Leptin signaling pathway	0.37018108301098	-0.993762979524424	76	1	0.03125	32	5314	3717	JAK2
WP2371	Parkinsons Disease Pathway	0.396641164003838	-0.924723276038816	83	1	0.03125	32	5314	839	CASP6
WP254	Apoptosis	0.407648577239419	-0.897349806031597	86	1	0.03125	32	5314	839	CASP6
WP138	Androgen receptor signaling pathway	0.42202291687697	-0.862695661024946	90	1	0.03125	32	5314	7337	UBE3A
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	0.425563358432537	-0.854341438569507	91	1	0.03125	32	5314	6885	MAP3K7
WP1772	Apoptosis Modulation and Signaling	0.436059084088127	-0.829977530850697	94	1	0.03125	32	5314	839	CASP6
WP23	B Cell Receptor Signaling Pathway	0.449764783981985	-0.799030535136478	98	1	0.03125	32	5314	6885	MAP3K7
WP2064	Neural Crest Differentiation	0.463147551817693	-0.769709589234334	102	1	0.03125	32	5314	1005	CDH7
WP75	Toll-like Receptor Signaling Pathway	0.466443652807069	-0.7626180531132	103	1	0.03125	32	5314	6885	MAP3K7
WP185	Integrin-mediated Cell Adhesion	0.466443652807069	-0.7626180531132	103	1	0.03125	32	5314	84665	MYPN
WP615	Senescence and Autophagy in Cancer	0.476214756641898	-0.741886357081283	106	1	0.03125	32	5314	81631	MAP1LC3B
WP710	DNA Damage Response (only ATM dependent)	0.501431143583242	-0.690288981937507	114	1	0.03125	32	5314	6885	MAP3K7
WP2431	Spinal Cord Injury	0.516589834576079	-0.660506076067083	119	1	0.03125	32	5314	3164	NR4A1
WP236	Adipogenesis	0.551171518125552	-0.595709233104057	131	1	0.03125	32	5314	2034	EPAS1
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.553942598849341	-0.590694209788271	132	1	0.03125	32	5314	6885	MAP3K7
WP2858	Ectoderm Differentiation	0.58335123976049	-0.538965804471554	143	1	0.03125	32	5314	57476	GRAMD1B
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.585929611506838	-0.534555613502264	144	1	0.03125	32	5314	3717	JAK2
WP1449	Regulation of toll-like receptor signaling pathway	0.588492523001753	-0.530191057542206	145	1	0.03125	32	5314	6885	MAP3K7
WP2853	Endoderm Differentiation	0.588492523001753	-0.530191057542206	145	1	0.03125	32	5314	79923	NANOG
WP536	Calcium Regulation in the Cardiac Cell	0.603550316312357	-0.504925867748722	151	1	0.03125	32	5314	2706	GJB2
WP1984	Integrated Breast Cancer Pathway	0.610877655268868	-0.492858576736451	154	1	0.03125	32	5314	6597	SMARCA4
WP289	Myometrial Relaxation and Contraction Pathways	0.620443636535177	-0.477320514023022	158	1	0.03125	32	5314	23764	MAFF
WP481	Insulin Signaling	0.627468213101593	-0.466062265671081	161	1	0.03125	32	5314	6885	MAP3K7
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.62978162610534	-0.462382144914589	162	1	0.03125	32	5314	79923	NANOG
WP702	Metapathway biotransformation	0.664957172422114	-0.408032642772966	178	1	0.03125	32	5314	54578	UGT1A6
WP3594	Circadian rythm related genes	0.720637472534144	-0.327619080168759	207	1	0.03125	32	5314	7337	UBE3A
WP2290	RalA downstream regulated genes	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP106	Alanine and aspartate metabolism	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.999999999982546	-1.74536132403747e-11	12	0	0	32	5314
WP524	G13 Signaling Pathway	0.999999999983409	-1.65909769504223e-11	40	0	0	32	5314
WP2516	ATM Signaling Pathway	0.999999999983409	-1.65909769504223e-11	40	0	0	32	5314
WP3875	ATR Signaling	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3297	EV release from cardiac cells and their functional effects	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3585	Cytosine methylation	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3674	Tgif disruption of Shh signaling	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP531	Mismatch repair	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3300	Dual hijack model of Vif in HIV infection	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP696	Benzo(a)pyrene metabolism	0.999999999984502	-1.54975859918435e-11	9	0	0	32	5314
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.999999999985024	-1.49761569634856e-11	51	0	0	32	5314
WP3646	Hepatitis C and Hepatocellular Carcinoma	0.999999999985024	-1.49761569634856e-11	51	0	0	32	5314
WP24	Peptide GPCRs	0.999999999985055	-1.49447275718289e-11	74	0	0	32	5314
WP1423	Ganglio Sphingolipid Metabolism	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP2881	Estrogen Receptor Pathway	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP1434	Osteopontin Signaling	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP186	Homologous recombination	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP3871	Valproic acid pathway	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999985784	-1.4215942958943e-11	13	0	0	32	5314
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	0.999999999985906	-1.40942886959947e-11	31	0	0	32	5314
WP712	Estrogen signaling pathway	0.999999999986244	-1.37561911495313e-11	23	0	0	32	5314
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.999999999986244	-1.37561911495313e-11	23	0	0	32	5314
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP3874	Canonical and Non-Canonical TGF-B signaling	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP78	TCA Cycle	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP554	ACE Inhibitor Pathway	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP2289	Drug Induction of Bile Acid Pathway	0.999999999986422	-1.35782360270159e-11	17	0	0	32	5314
WP534	Glycolysis and Gluconeogenesis	0.999999999987874	-1.21258037524704e-11	49	0	0	32	5314
WP410	Diurnally Regulated Genes with Circadian Orthologs	0.999999999987874	-1.21258037524704e-11	49	0	0	32	5314
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	0.99999999998813	-1.18694706269625e-11	73	0	0	32	5314
WP1133	Androgen receptor signaling pathway	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP2889	Oxytocin signaling	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP2491	Diclofenac Metabolic Pathway	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP1603	Nicotine Activity on Chromaffin Cells	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP521	Amino acid conjugation of benzoic acid	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP3633	Caffeine and Theobromine metabolism	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP2253	Pilocytic astrocytoma	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP690	Polyol Pathway	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP897	Androgen receptor signaling pathway	0.999999999988287	-1.17128796983863e-11	4	0	0	32	5314
WP2586	Aryl Hydrocarbon Receptor	0.999999999988466	-1.15336459745083e-11	48	0	0	32	5314
WP2848	Differentiation Pathway	0.999999999988466	-1.15336459745083e-11	48	0	0	32	5314
WP2849	Hematopoietic Stem Cell Differentiation	0.999999999988466	-1.15336459745083e-11	48	0	0	32	5314
WP2361	Gastric Cancer Network 1	0.999999999988665	-1.13347792454127e-11	28	0	0	32	5314
WP2249	Metastatic brain tumor	0.999999999988665	-1.13347792454127e-11	28	0	0	32	5314
WP2525	Trans-sulfuration and one carbon metabolism	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP727	Monoamine Transport	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP2828	Bladder Cancer	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP34	Ovarian Infertility Genes	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP3858	Toll-like Receptor Signaling	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP3893	Development and heterogeneity of the ILC family	0.999999999988711	-1.12893783564235e-11	32	0	0	32	5314
WP134	Pentose Phosphate Pathway	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP1995	Effects of Nitric Oxide	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP699	Aflatoxin B1 metabolism	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP1272	Selenium Micronutrient Network	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP3924	Hfe effect on hepcidin production	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP1310	Selenium Micronutrient Network	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP438	Non-homologous end joining	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP3595	mir-124 predicted interactions with cell cycle and differentiation	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP2596	Gastric acid production	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP2805	RNA interference	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP528	Acetylcholine Synthesis	0.999999999988929	-1.10708503728115e-11	7	0	0	32	5314
WP3408	Evolocumab Mechanism	0.999999999989443	-1.05571510051894e-11	3	0	0	32	5314
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	0.999999999989443	-1.05571510051894e-11	3	0	0	32	5314
WP1545	miRNAs involved in DNA damage response	0.999999999989777	-1.0222843915129e-11	50	0	0	32	5314
WP411	mRNA Processing	0.999999999989826	-1.01742969441482e-11	132	0	0	32	5314
WP477	Cytoplasmic Ribosomal Proteins	0.999999999989954	-1.00461998248623e-11	90	0	0	32	5314
WP26	Signal Transduction of S1P Receptor	0.999999999990325	-9.67487087080471e-12	26	0	0	32	5314
WP530	Cytokines and Inflammatory Response	0.999999999990325	-9.67487087080471e-12	26	0	0	32	5314
WP325	Triacylglyceride Synthesis	0.999999999990325	-9.67487087080471e-12	26	0	0	32	5314
WP2878	PPAR Alpha Pathway	0.999999999990325	-9.67487087080471e-12	26	0	0	32	5314
WP430	Statin Pathway	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP2197	Endothelin Pathways	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP3676	BDNF-TrkB Signaling	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP453	Inflammatory Response Pathway	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP58	Monoamine GPCRs	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP2363	Gastric Cancer Network 2	0.999999999990494	-9.50625937175134e-12	33	0	0	32	5314
WP143	Fatty Acid Beta Oxidation	0.999999999990629	-9.37123246655573e-12	34	0	0	32	5314
WP1601	Fluoropyrimidine Activity	0.999999999990629	-9.37123246655573e-12	34	0	0	32	5314
WP313	Signaling of Hepatocyte Growth Factor Receptor	0.999999999990629	-9.37123246655573e-12	34	0	0	32	5314
WP1971	Integrated Cancer Pathway	0.999999999990901	-9.09870436679493e-12	46	0	0	32	5314
WP1591	Heart Development	0.999999999990901	-9.09870436679493e-12	46	0	0	32	5314
WP268	Notch Signaling Pathway	0.999999999990901	-9.09870436679493e-12	46	0	0	32	5314
WP28	Selenium Metabolism and Selenoproteins	0.999999999990901	-9.09870436679493e-12	46	0	0	32	5314
WP3878	ATM Signaling Network in Development and Disease	0.999999999990901	-9.09870436679493e-12	46	0	0	32	5314
WP2267	Synaptic Vesicle Pathway	0.999999999990955	-9.04500859877555e-12	52	0	0	32	5314
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.999999999991251	-8.74878209505797e-12	30	0	0	32	5314
WP129	Matrix Metalloproteinases	0.999999999991251	-8.74878209505797e-12	30	0	0	32	5314
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.999999999991251	-8.74878209505797e-12	30	0	0	32	5314
WP98	Prostaglandin Synthesis and Regulation	0.999999999991251	-8.74878209505797e-12	30	0	0	32	5314
WP2855	Dopaminergic Neurogenesis	0.999999999991251	-8.74878209505797e-12	30	0	0	32	5314
WP1530	miRNA Regulation of DNA Damage Response	0.999999999991503	-8.49735917903605e-12	93	0	0	32	5314
WP111	Electron Transport Chain	0.999999999991503	-8.49735917903605e-12	93	0	0	32	5314
WP179	Cell Cycle	0.999999999991757	-8.24316531967486e-12	105	0	0	32	5314
WP334	GPCRs, Class B Secretin-like	0.999999999992106	-7.89362575588429e-12	24	0	0	32	5314
WP2509	Nanoparticle triggered autophagic cell death	0.999999999992106	-7.89362575588429e-12	24	0	0	32	5314
WP1539	Angiogenesis	0.999999999992106	-7.89362575588429e-12	24	0	0	32	5314
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.999999999992106	-7.89362575588429e-12	24	0	0	32	5314
WP1602	Nicotine Activity on Dopaminergic Neurons	0.999999999992172	-7.82833759068597e-12	21	0	0	32	5314
WP2533	Glycerophospholipid Biosynthetic Pathway	0.999999999992172	-7.82833759068597e-12	21	0	0	32	5314
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.999999999992172	-7.82833759068597e-12	21	0	0	32	5314
WP691	Tamoxifen metabolism	0.999999999992172	-7.82833759068597e-12	21	0	0	32	5314
WP3286	Copper homeostasis	0.999999999992378	-7.62181395712129e-12	54	0	0	32	5314
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.999999999992378	-7.62181395712129e-12	54	0	0	32	5314
WP673	ErbB Signaling Pathway	0.999999999992378	-7.62181395712129e-12	54	0	0	32	5314
WP623	Oxidative phosphorylation	0.999999999992378	-7.62181395712129e-12	54	0	0	32	5314
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.99999999999256	-7.43993033280434e-12	76	0	0	32	5314
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP3596	miR-517 relationship with ARCN1 and USP1	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP2542	Sulindac Metabolic Pathway	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP311	Synthesis and Degradation of Ketone Bodies	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.999999999992578	-7.42182963761407e-12	5	0	0	32	5314
WP2436	Dopamine metabolism	0.999999999992848	-7.15237101888421e-12	14	0	0	32	5314
WP3853	ERK Pathway in Huntington's Disease	0.999999999992848	-7.15237101888421e-12	14	0	0	32	5314
WP322	Osteoblast Signaling	0.999999999992848	-7.15237101888421e-12	14	0	0	32	5314
WP229	Irinotecan Pathway	0.999999999992848	-7.15237101888421e-12	14	0	0	32	5314
WP2526	PDGF Pathway	0.999999999993126	-6.8742438140464e-12	38	0	0	32	5314
WP2029	Cell Differentiation - Index	0.999999999993126	-6.8742438140464e-12	38	0	0	32	5314
WP2447	Amyotrophic lateral sclerosis (ALS)	0.999999999993126	-6.8742438140464e-12	38	0	0	32	5314
WP428	Wnt Signaling Pathway	0.999999999993156	-6.84439654625389e-12	70	0	0	32	5314
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.999999999993156	-6.84439654625389e-12	70	0	0	32	5314
WP2646	Lidocaine metabolism	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP2366	Butyrate-induced histone acetylation	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP2816	Felbamate Metabolism	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP2943	Hypoxia-mediated EMT and Stemness	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP1273	Folic Acid Network	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP1311	Folic Acid Network	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP1438	Influenza A virus infection	0.999999999993788	-6.21251330544179e-12	2	0	0	32	5314
WP1455	Serotonin Transporter Activity	0.999999999993887	-6.11292645927105e-12	11	0	0	32	5314
WP3630	NAD metabolism, sirtuins and aging	0.999999999993887	-6.11292645927105e-12	11	0	0	32	5314
WP80	Nucleotide GPCRs	0.999999999993887	-6.11292645927105e-12	11	0	0	32	5314
WP2854	Gene regulatory network modelling somitogenesis	0.999999999993887	-6.11292645927105e-12	11	0	0	32	5314
WP405	Eukaryotic Transcription Initiation	0.999999999994221	-5.77905238288481e-12	42	0	0	32	5314
WP466	DNA Replication	0.999999999994221	-5.77905238288481e-12	42	0	0	32	5314
WP2636	Common Pathways Underlying Drug Addiction	0.999999999994221	-5.77905238288481e-12	42	0	0	32	5314
WP49	IL-2 Signaling Pathway	0.999999999994221	-5.77905238288481e-12	42	0	0	32	5314
WP244	Alpha 6 Beta 4 signaling pathway	0.999999999994535	-5.46496126915738e-12	35	0	0	32	5314
WP3617	Photodynamic therapy-induced NF-kB survival signaling	0.999999999994535	-5.46496126915738e-12	35	0	0	32	5314
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.999999999994535	-5.46496126915738e-12	35	0	0	32	5314
WP1471	Target Of Rapamycin (TOR) Signaling	0.999999999995168	-4.83246495763241e-12	37	0	0	32	5314
WP3529	Zinc homeostasis	0.999999999995168	-4.83246495763241e-12	37	0	0	32	5314
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	0.999999999995168	-4.83246495763241e-12	37	0	0	32	5314
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.999999999995168	-4.83246495763241e-12	37	0	0	32	5314
WP474	Endochondral Ossification	0.999999999995813	-4.18720066083864e-12	65	0	0	32	5314
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.999999999996033	-3.96715519008365e-12	18	0	0	32	5314
WP692	Sulfation Biotransformation Reaction	0.999999999996033	-3.96715519008365e-12	18	0	0	32	5314
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.999999999996033	-3.96715519008365e-12	18	0	0	32	5314
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.999999999996033	-3.96715519008365e-12	18	0	0	32	5314
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	0.999999999996033	-3.96715519008365e-12	18	0	0	32	5314
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.999999999996111	-3.88870985716691e-12	68	0	0	32	5314
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.999999999996111	-3.88870985716691e-12	68	0	0	32	5314
WP45	G1 to S cell cycle control	0.999999999996111	-3.88870985716691e-12	68	0	0	32	5314
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.999999999996111	-3.88870985716691e-12	68	0	0	32	5314
WP1981	Thyroxine (Thyroid Hormone) Production	0.999999999996689	-3.31070695514716e-12	6	0	0	32	5314
WP694	Arylamine metabolism	0.999999999996689	-3.31070695514716e-12	6	0	0	32	5314
WP1600	Nicotine Metabolism	0.999999999996689	-3.31070695514716e-12	6	0	0	32	5314
WP3891	Benzene metabolism	0.999999999996689	-3.31070695514716e-12	6	0	0	32	5314
WP2012	miRs in Muscle Cell Differentiation	0.999999999996716	-3.28391665182482e-12	36	0	0	32	5314
WP500	Glycogen Metabolism	0.999999999996716	-3.28391665182482e-12	36	0	0	32	5314
WP3298	Melatonin metabolism and effects	0.999999999996716	-3.28391665182482e-12	36	0	0	32	5314
WP585	Interferon type I signaling pathways	0.999999999997309	-2.69139576012277e-12	55	0	0	32	5314
WP560	TGF-beta Receptor Signaling	0.999999999997581	-2.418785185685e-12	58	0	0	32	5314
WP2328	Allograft Rejection	0.999999999998068	-1.93214078931692e-12	80	0	0	32	5314
WP716	Vitamin A and Carotenoid Metabolism	0.999999999998446	-1.5536983777305e-12	44	0	0	32	5314
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.999999999998583	-1.41687805272434e-12	25	0	0	32	5314
WP205	IL-7 Signaling Pathway	0.999999999998583	-1.41687805272434e-12	25	0	0	32	5314
WP2865	IL1 and megakaryocytes in obesity	0.999999999998583	-1.41687805272434e-12	25	0	0	32	5314
WP2895	Differentiation of white and brown adipocyte	0.999999999998583	-1.41687805272434e-12	25	0	0	32	5314
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.999999999998583	-1.41687805272434e-12	25	0	0	32	5314
WP3845	Canonical  and Non-canonical Notch signaling	0.999999999998694	-1.30642432332217e-12	27	0	0	32	5314
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	0.999999999998694	-1.30642432332217e-12	27	0	0	32	5314
WP3624	Lung fibrosis	0.999999999998884	-1.11638382856113e-12	63	0	0	32	5314
WP43	Oxidation by Cytochrome P450	0.999999999998884	-1.11638382856113e-12	63	0	0	32	5314
WP306	Focal Adhesion	0.999999999998905	-1.09538064445757e-12	195	0	0	32	5314
WP550	Biogenic Amine Synthesis	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP1946	Cori Cycle	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP3644	NAD+ metabolism	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP47	Hedgehog Signaling Pathway	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP53	ID signaling pathway	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP12	Osteoclast Signaling	0.999999999998998	-1.00210106643247e-12	16	0	0	32	5314
WP707	DNA Damage Response	0.999999999999042	-9.57944066006452e-13	69	0	0	32	5314
WP183	Proteasome Degradation	0.999999999999087	-9.13182286016872e-13	66	0	0	32	5314
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	0.999999999999087	-9.13182286016872e-13	66	0	0	32	5314
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP100	Glutathione metabolism	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP357	Fatty Acid Biosynthesis	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP545	Complement Activation	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP1424	Globo Sphingolipid Metabolism	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP3645	NAD+ biosynthetic pathways	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP3599	Transcription factor regulation in adipogenesis	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP167	Eicosanoid Synthesis	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP1584	Type II diabetes mellitus	0.999999999999171	-8.2913051287183e-13	22	0	0	32	5314
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP497	Urea cycle and metabolism of amino groups	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP1742	TP53 Network	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP391	Mitochondrial Gene Expression	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP516	Hypertrophy Model	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP1422	Sphingolipid Metabolism	0.999999999999291	-7.09073666981349e-13	20	0	0	32	5314
WP51	Regulation of Actin Cytoskeleton	1.00000000000022	2.22517002675596e-13	149	0	0	32	5314
WP2536	Colchicine Metabolic Pathway	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP188	Focal Adhesion	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP1	Statin Pathway	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP108	Selenium metabolism/Selenoproteins	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP661	Glucose Homeostasis	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP2190	One carbon donor	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP3627	Gut-Liver Indole Metabolism	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP3191	TSLP Signaling Pathway	1.00000000000037	3.6875450609708e-13	1	0	0	32	5314
WP3407	FTO Obesity Variant Mechanism	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP136	Phase I biotransformations, non P450	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP1604	Codeine and Morphine Metabolism	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP2276	Glial Cell Differentiation	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP2338	miRNA Biogenesis	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000041	4.05198446638725e-13	8	0	0	32	5314
WP35	G Protein Signaling Pathways	1.00000000000068	6.80195929858863e-13	96	0	0	32	5314
WP117	GPCRs, Other	1.00000000000097	9.7160752950392e-13	95	0	0	32	5314
WP2059	Alzheimers Disease	1.00000000000152	1.52125029227585e-12	148	0	0	32	5314
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000184	1.84031454136588e-12	15	0	0	32	5314
WP206	Fatty Acid Omega Oxidation	1.00000000000184	1.84031454136588e-12	15	0	0	32	5314
WP3	Transcriptional activation by NRF2	1.00000000000184	1.84031454136588e-12	15	0	0	32	5314
WP197	Cholesterol Biosynthesis	1.00000000000184	1.84031454136588e-12	15	0	0	32	5314
WP3925	Amino Acid metabolism	1.00000000000192	1.92434396474276e-12	91	0	0	32	5314
WP2261	Signaling Pathways in Glioblastoma	1.00000000000198	1.98444907504873e-12	83	0	0	32	5314
WP2583	T-Cell Receptor and Co-stimulatory Signaling	1.00000000000206	2.05596440532073e-12	29	0	0	32	5314
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000206	2.05596440532073e-12	29	0	0	32	5314
WP422	MAPK Cascade	1.00000000000206	2.05596440532073e-12	29	0	0	32	5314
WP3613	Photodynamic therapy-induced unfolded protein response	1.00000000000206	2.05596440532073e-12	29	0	0	32	5314
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP1992	TarBasePathway	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP22	IL-9 Signaling Pathway	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP3287	Overview of nanoparticle effects	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP247	Small Ligand GPCRs	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP404	Nucleotide Metabolism	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP2879	Farnesoid X Receptor  Pathway	1.00000000000232	2.31616505986163e-12	19	0	0	32	5314
WP2911	miRNA targets in ECM and membrane receptors	1.00000000000273	2.72767293815927e-12	43	0	0	32	5314
WP2446	Retinoblastoma (RB) in Cancer	1.00000000000351	3.50766629517133e-12	88	0	0	32	5314
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1.00000000000396	3.95799400746369e-12	102	0	0	32	5314
WP15	Selenium Micronutrient Network	1.00000000000405	4.0502720913708e-12	87	0	0	32	5314
WP1533	Vitamin B12 Metabolism	1.00000000000462	4.62137313973029e-12	53	0	0	32	5314
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000000537	5.36831893685687e-12	41	0	0	32	5314
WP2874	Liver X Receptor Pathway	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP704	Methylation Pathways	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP1531	Vitamin D Metabolism	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP2333	Trans-sulfuration pathway	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP2113	Type III interferon signaling	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP496	Steroid Biosynthesis	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP3601	Composition of Lipid Particles	1.00000000000578	5.7767231516602e-12	10	0	0	32	5314
WP455	GPCRs, Class A Rhodopsin-like	1.0000000000129	1.28951751171464e-11	259	0	0	32	5314
